Role of pertuzumab in the treatment of HER2-positive breast cancer
Michael Hubalek(Innsbruck Medical University), Christian Marth(Nordic Society of Gynecologic Oncology), Christine A. Brantner(University of Maryland, Baltimore)
Cited by 20
Related Papers
Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
|New England Journal of Medicine|2016|2.5k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.4k
ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer
|International Journal of Gynecological Cancer|2015|757